In addition, we found no statistically significant difference in Olig2 expression, which, together with the PDGFR-α with KI67 staining results, suggests that the lack of remyelination in MS is likely due to a failure of OPCs differentiation rather than a lack of OPCs. This evidence concerns the gene OLIG2 and myeloid sarcoma.